As COVID Wanes, Tuberculosis Deaths Must Become Visible
Tuberculosis has killed 1,5 million people in 2020 - mostly in African and Asian countries - while two million people died of COVID-19 worldwide during the same period. Credit: Athar Parvaiz/IPSBy Angelique Luabeya Kany KanyCAPE TOWN, South Africa, May 19 2022 (IPS) It is time to treat the scourge of Tuberculosis scourge with the same urgency as we did the COVID-19 pandemic. As we emerge from the devastating toll of the pandemic on people’s lives and on global economies, we must wake up to face the staggering toll of 1.5 million Tuberculosis deaths and 10 million new infections recorded in 2020. And these deaths wer...
Source: IPS Inter Press Service - Health - May 19, 2022 Category: International Medicine & Public Health Authors: Angelique Luabeya Kany Kany Tags: Africa Headlines Health Poverty & SDGs TerraViva United Nations tuberculosis Source Type: news

Nigeria: Keeping Hope Alive - Waiting for an HIV Vaccine
[Nigeria Health Watch] HIV is no longer the death sentence it used to be. Today, more people living with HIV have access to life-saving treatment and can stay healthy by achieving and maintaining viral suppression. Unfortunately, newly acquired infections still occur and in 2019, approximately 1.7 million were reported globally. It is therefore critical for the world to move from managing HIV infections to preventing them. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - May 19, 2022 Category: Infectious Diseases Source Type: news

New Medicines May Help End AIDS – but High Prices & Monopolies Could Keep the Poor Locked Out
A man is tested for HIV at a health centre in Odienné, Côte d’Ivoire. Credit: UNICEF/Frank DejonghBy Matthew Kavanagh and Eamonn MurphyWASHINGTON DC, May 18 2022 (IPS) Here’s the good news: there are a new set of breakthrough medicines to prevent and treat HIV, known as “long actings” because they can be taken every few months instead of every day, and they are coming on-stream. If, as they are rolled out, they are made available at scale, they could help save many lives and help end the AIDS pandemic. But here’s the bad news: on the current trajectory, most people who need them will not be able to get them an...
Source: IPS Inter Press Service - Health - May 18, 2022 Category: International Medicine & Public Health Authors: Matthew Kavanagh and Eamonn Murphy Tags: Development & Aid Featured Global Headlines Health Poverty & SDGs Regional Categories IPS UN Bureau Source Type: news

Ron Johnson and the COVID Disinformation Pipeline
(MedPage Today) -- Senator Ron Johnson (R-Wis.) appeared in an interview with anti-vaccine lawyer Todd Callender, JD, last week and made headlines for saying it "may be true" that the COVID-19 vaccines cause AIDS. This came after Callender's flagrantly... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 17, 2022 Category: American Health Source Type: news

Immune Response After BNT162b2 Vaccination in HIV on ART Immune Response After BNT162b2 Vaccination in HIV on ART
How effective is the BNT162b2 COVID-19 vaccine among people living with HIV?HIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 12, 2022 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Here ’s What You Need to Know About Paxlovid
Prescriptions for Pfizer’s COVID-19 antiviral medication Paxlovid—the first such pill to be authorized by the U.S. Food and Drug Administration (FDA)—have increased tenfold in the past two months. Between late February and April 22, the number of patients using Paxlovid jumped from 8,000 to 80,000, according to Pfizer CEO Albert Bourla; the drug is now available at some 33,000 locations, such as pharmacies and outpatient clinics, across the country. On April 26, the White House announced it would step up its efforts to encourage more doctors to prescribe the antiviral medication. As part of this, the Bide...
Source: TIME: Health - May 9, 2022 Category: Consumer Health News Authors: Kyla Mandel Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

South Africa: Aurum Institute Set to Reveal Groundbreaking Research On HIV Vaccine
[Daily Maverick] On 18 May, the world will mark HIV Vaccine Awareness Day -- the Aurum Institute, in partnership with the International Aids Vaccine Initiative, will unveil new research on HIV vaccines. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - May 5, 2022 Category: Infectious Diseases Source Type: news

HHS: Solicitation of Nominations for Membership on the National Vaccine Advisory Committee
The U.S. Department of Health and Human Services (HHS) Office of Infectious Disease and HIV/AIDS Policy (OIDP) is seeking nominations of qualified candidates to be considered for appointment to the National Vaccine Advisory Committee (NVAC). The committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States, as well as research priorities and other measures to enhance the safety and efficacy of vaccines. Nominations are due by June 24, 2022. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - May 4, 2022 Category: Rural Health Source Type: news

Why I Recommend Hepatitis B Vaccination to All My Patients Why I Recommend Hepatitis B Vaccination to All My Patients
New age-based hepatitis B vaccine recommendations and available vaccine products are reviewed by Dr Sandra Fryhofer.Medscape Internal Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 3, 2022 Category: Infectious Diseases Tags: Internal Medicine Commentary Source Type: news

Nigeria: Covid-19 - Only 7.1% Nigerians Have Been Vaccinated - AHF
[Daily Trust] Only 14.6million are fully vaccinated against COVID-19 in Nigeria as of April 28, 2022, representing 7.1 per cent of the population, according to AIDS Healthcare Foundation (AHF). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 3, 2022 Category: African Health Source Type: news

COVID-19 Vaccination Among Persons Living With HIV Infection COVID-19 Vaccination Among Persons Living With HIV Infection
People living with HIV are at increased risk for severe COVID-19 outcomes, but this report showed that COVID-19 vaccination coverage among this group was lower than in the general population.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 2, 2022 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news

Safety and Immunogenicity of SARS-CoV-2 Vaccines in HIV Safety and Immunogenicity of SARS-CoV-2 Vaccines in HIV
Two doses of the SARS-CoV-2 mRNA vaccines are effective and well tolerated with no reported adverse events among people with HIV receiving ART.AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 18, 2022 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

As COVID-Era Restrictions End, Disabled Americans Want to Avoid a ‘Return to Normal’
President Joe Biden hired Kim Knackstedt in early 2021 to make sure that Americans with disabilities were not forgotten as the country returned to normal after the COVID-19 pandemic. A year later, that seems to be precisely what has happened—and it’s unfortunate, Knackstedt says. “What was considered ‘normal’ was actually not a great way to live, often,” says Knackstedt, who served as the first White House director of disability policy, before leaving the administration on March 11. “It wasn’t accessible. It actually didn’t provide all of the things that we needed to ge...
Source: TIME: Health - April 15, 2022 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 Source Type: news

Well-Controlled HIV Does Not Impair mRNA Vaccine Response Well-Controlled HIV Does Not Impair mRNA Vaccine Response
People living with well-controlled HIV infections are likely to have immune responses to the mRNA COVID-19 vaccines from Moderna and from Pfizer/BioNTech similar to those of otherwise healthy individuals, according to new data.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 13, 2022 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

MenB Vaccine Provides Moderate Protection Against Gonorrhea MenB Vaccine Provides Moderate Protection Against Gonorrhea
Two observational studies suggest that fully vaccinated individuals were up to 40% less likely to contract the STI.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 13, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news